Daily Health Headlines

Sexual Pain for Women With Cancer Should Not Be Overlooked: Report

👤by HealthDay 0 comments 🕔Monday, November 14th, 2016

FRIDAY, Nov. 11, 2016 (HealthDay News) -- Painful sex is common, though often treatable, in women with cancer, yet doctors often overlook it, researchers say.

"Sexual pain is often written off as 'in people's heads,' but it is more often a result of physical issues that can be helped," said Dr. Vanessa Kennedy, an assistant professor of gynecologic oncology at the University of California, Davis, Health System.

"It is important to be able to have the conversation comfortably and to know how to address the common issues that are often predictable, depending on a patient's treatment course," she said in a university news release.

In their review paper, Kennedy and co-author Dr. Deborah Coady, from NYU Langone Medical Center, outlined several causes of painful sex in women with cancer, and listed treatments such as surgery, chemotherapy, radiation and hormone therapy.

A low estrogen level is most often to blame. It usually stems from hormone therapy, ovary removal or radiation to the pelvic region, Kennedy said.

"Diagnosing a purely psychological basis for sexual pain is only appropriate after biologic causes have been completely evaluated and ruled out," Kennedy added.

She said gynecologists should work with cancer specialists to learn more about the possible effects of a patient's cancer therapy.

Most women find it hard to bring up sexual difficulties and would prefer their doctors to ask about it, according to Kennedy.

"Time and time again, I see women who have had negative impacts for years following cancer therapy. It's an incredible relief for them to be able to just sit down and have the conversation," she said.

The paper was published recently in the journal Obstetrics & Gynecology.

-- Robert Preidt

Article Credits / Source

HealthDay

HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: University of California, Davis, news release, Oct. 20, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!